Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy

被引：2
|
作者：
Westin, Jason R. [1 ]
Thompson, Michael A. [2 ]
Cataldo, Vince D. [3 ]
Toth, Bela B. [4 ]
Sanjorjo, Perpetua [5 ]
Bourgeois, Scott [5 ]
Jimenez, Camilo [6 ]
Murphy, William A. [7 ]
Fanale, Michelle [5 ]
Fayad, Luis [5 ]
Fowler, Nathan [5 ]
Kwak, Larry [5 ]
McLaughlin, Peter [5 ]
Neelapu, Sattva [5 ]
Pro, Barbara [5 ]
Rodriguez, Alma [5 ]
Shah, Jatin [5 ]
Hagemeister, Fredrick B. [5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Waukesha Mem Hosp, ProHlth Care Canc Ctr, Waukesha, WI USA
[3] Louisiana State Univ, New Orleans, LA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Dent Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2010年 / 10卷 / 03期
关键词：
D O I：
10.3816/CLML.2010.n.042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7
引用
收藏
页码：E32 / E32
页数：1
相关论文
共 50 条
  • [1] Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma
    Prince, HM
    Crump, M
    Imrie, K
    Stewart, AK
    Girouard, C
    Brandwein, JM
    Carstairs, K
    Pantalony, D
    Scott, G
    Sutcliffe, S
    Sutton, DMC
    Tsang, R
    Keating, A
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 1043 - 1049
  • [2] Primary Bone Lymphoma: Evaluation of Chemoimmunotherapy as Front-line Treatment in 21 Patients
    Pellegrini, Cinzia
    Gandolfi, Letizia
    Quirini, Federica
    Ruggieri, Pietro
    Stefoni, Vittorio
    Derenzini, Enrico
    Broccoli, Alessandro
    Argnani, Lisa
    Pileri, Stefano
    Mercuri, Mario
    Baccarani, Michele
    Zinzani, Pier Luigi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (04): : 321 - 325
  • [3] Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
    Haige Ye
    Aakash Desai
    Shengjian Huang
    Dayoung Jung
    Richard Champlin
    Dongfeng Zeng
    Fangfang Yan
    Krystle Nomie
    Jorge Romaguera
    Makhdum Ahmed
    Michael L. Wang
    Journal of Experimental & Clinical Cancer Research, 37
  • [4] Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
    Ye, Haige
    Desai, Aakash
    Huang, Shengjian
    Jung, Dayoung
    Champlin, Richard
    Zeng, Dongfeng
    Yan, Fangfang
    Nomie, Krystle
    Romaguera, Jorge
    Ahmed, Makhdum
    Wang, Michael L.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [5] Patients with front-line therapy of aggressive lymphoma can profit from additional radiotherapy
    Poeschel, V
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 122 - 122
  • [6] Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma
    Acedo, Rocio Diaz
    Criado, Silvia Artacho
    Herranz, Eduardo Rios
    Pizarraya, Antonio Gutierrez
    Romero, Irene Sanchez
    Saavedra, Esther Marquez
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (08) : 1982 - 1989
  • [7] The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy
    Westin, Jason
    Hagemeister, Fredrick
    Thompson, Michael A.
    Cataldo, Vince D.
    Toth, Bela B.
    Sanjorjo, Perpetua
    Bourgeois, Scott
    Jimenez, Camilo
    Murphy, William A.
    Fanale, Michelle
    Fayad, Luis
    Fowler, Nathan
    Kwak, Larry
    McLaughlin, Peter
    Neelapu, Sattva
    Pro, Barbara
    Rodriguez, Alma
    Shah, Jatin
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : E30 - E30
  • [8] Optimal front-line ALK (anaplastic lymphoma kinase) directed therapy
    Gadgeel, Shirish M.
    LUNG CANCER, 2017, 109 : 147 - 148
  • [9] Front-line treatment of mantle cell lymphoma
    Geisler, Christian H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1241 - 1243
  • [10] The effect of zoledronic acid on the prevention of bone loss in lymphoma patients receiving first-line therapy.
    Westin, J. R.
    Hagemeister, F. B.
    Thompson, M. A.
    Cataldo, V. D.
    Toth, B. B.
    Sanjorjo, P.
    Bourgeois, S.
    Jimenez, C.
    Murphy, W. A.
    Kwak, L. W.
    Anderson, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345